I, Emmanuel Addo-Yobo, residing in Ghana, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Professor in the Department of Child Health, Kwame Nkrumah University of Science and Technology (KNUST), School of Medical Sciences (SMS), and Honorary Consultant Paediatrician with sub-specialty interest in paediatric pulmonology in the Directorate of Child Health, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. My responsibilities include general paediatric clinical care, clinical teaching and mentoring of undergraduate and postgraduate medical students. I am seconded by KNUST-SMS, to support clinical teaching of medical students in Child Health at the Asokwa Childrens’ Hospital, Kumasi, as its external clinical teaching site. There, I am also in charge of clinical education as a member of the hospital board. I have been involved in many research activities on childhood asthma epidemiology in Ghana as Principal or Co-Investigator, some of which have been sponsored partly or fully by pharmaceutical companies. I do not receive any form of remuneration from any drug companies. I have, however, given educational lectures to medical personnel on childhood asthma in Ghana which were sponsored by drug companies in a purely academic capacity.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: My business has an interest in the topics of the Montreal Protocol with regard to patients I attend to with asthma and COPD who may be using MDIs containing ODS where there are no other affordable and effective alternatives. My spouse is a business secretary working with a local financial institution in Ghana and has no interests in matters before the Protocol.
   • Government advice and other policy development: I served as a member of the National Expert Committee to review Standard Treatment Guidelines for Ghana (2016-2017). My role in this Committee included advising prescribers on safe and cost-effective treatments for asthma and COPD, and other disorders in my capacity as a clinician. I have been involved in discussions on asthma treatment guidelines for the Ghana Thoracic Society (2023). I am also the current chair of the National Poliomyelitis Expert Committee (NPEC) as part of Ghana’s poliomyelitis eradication activities.
   • Paid research activities, fellowships or grants: I am currently the country Principal Investigator for a multi -African country asthma study - “Achieving Control of Asthma in Children in Africa (ACACIA) Study” - and a sub-study on air pollution and asthma – “Children’s Air Pollution Profiles in Africa (CAPPA) Study”, aspects of which involve information on use of asthma medications in children.
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is the Ozone Secretariat of the United Nations Environmental Programme (UNEP).
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Emmanuel Addo-Yobo
Date: 2026-01-29

I, Fatima AlShatti , residing in Kuwait, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an Environment Advisor with the Kuwait Environment Public Authority. I am providing government advice.to the Kuwait EPA.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have an interest in the work of the MCTOC and the outcomes of the Montreal Protocol because of my consulting role with KEPA
   • Government advice and other policy development: Yes in my role I provide consulting advice to the Kuwait Government about the Montreal Protocol, including about compliance requirements.
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is UNEP’s Ozone Secretariat
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Fatima AlShatti
Date: 2026-01-17

I, Paul J Atkins, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a retired Pharmaceutical Executive who has worked on the Development and Commercialization of inhaled products (MDIs, DPIs and Nebulizers) for over 35 years. I currently serve as Executive Chairman of Nob Hill Therapeutics, a pre-clinical company that is developing a novel dry powder nebulizer.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. My wife owns shares in AstraZeneca a company that develops and manufactures inhalers
   • Employment, consultancy, directorship or other positions: I am Chairman of a company (Nob Hill Therapeutics) that is developing a novel inhaled powder delivery system
   • Government advice and other policy development: N/A
   • Paid research activities, fellowships or grants: N/A
   • Other interests: N/A
5. The source of funding for my participation in the work of TEAP are my own funds
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Paul J Atkins
Date: 2026-01-28

I, Christian SEKOMO BIRAME, residing in Rwanda, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Director General of the National Industrial Research and Development Agency (NIRDA) and part time Lecturer at the University of Rwanda (UR) in the College of Science and Technology (CST) / School of Science (SoS) / Department of Chemistry. I used to teach the following modules: Analytical Chemistry I & II; Environmental Chemistry I, Fundamental of waste management at undergraduate level and Water Quality Principles and Management; Wastewater Treatment and Disposal; Supervision of laboratory work and BSc final year project as well as MSC and PhD thesis. Beside my daily workload, I used to conduct many consultancies services for the Ministry of Environment and REMA mainly related with waste management in general (water quality analysis; Hazardous chemical waste management (POPs, PCBs and Hg).
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have an interest to conduct consultancy services in the topics of the Montreal Protocol because my potential client is also interested in these topics. I consult for an organization that supports the Montreal Protocol in phasing out controlled substances.
   • Government advice and other policy development: See above comment
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is provided by the Ozone Secretariat to support travel and accommodation when I will be attending MCTOC planned meetings.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Christian SEKOMO BIRAME
Date: 2026-02-03

I, Steve burns, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Global Product Leader at Astrazeneca. I lead the development of new medicines for respiratory and inflammatory diseases. I support MCTOC by providing knowledge about the treatment of respiratory diseases and the technical opportunities and challenges associated with changing inhalers to more environmentally friendly options.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I have shares and share options in AstraZeneca which currently develops and manufactures inhaled products for respiratory treatments (including pMDIs).
   • Employment, consultancy, directorship or other positions: None
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is AstraZeneca/personal.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Steve burns
Date: 2026-01-16

I, Nick Campbell, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am retired.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: None
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: I am a Fellow of the International Emissions Trading Association.
   • Other interests: None
5. I have no source of funding for my participation in the work of MCTOC. I have been able to travel to OEWG and MOP meetings through funding for travel, accommodation and living expenses through the UK Government.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Nick Campbell
Date: 2026-02-02

I, Andrea Casazza, residing in Italy, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am responsible for the technical product development of pharmaceutical products for Chiesi Farmaceutici. My organization is in charge to follow chemical, formulation and device development of inhalation, injectable and oral products. The development of inhalation products is of particular interest and this includes the use of propellants for the development of pressurised metered dose inhalers (pMDIs).
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: As an employer of Chiesi Farmaceutici, I have interest in the topic of Montreal Proptocol because we are manufacturing pMDI products containing HFC and Dry Powder for inhalation (DPI); we are committed to develop alternative low global warming potential pMDIs.
   • Government advice and other policy development: No  
   • Paid research activities, fellowships or grants: No
   • Other interests: NO
5. The source of funding for my participation in the work of TEAP is Chiesi Farmaceutici
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2025 after I have signed it.

Signed: Andrea Casazza 
Date: 2025-02-04 
 

I, Richard J Cooke, residing in Canada, a Member of the Medical and Chemicals Technical Options Committee and Consulting Expert of the TEAP Replenishment Task Force (RTF) declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a principal in a Canadian consulting company (Man-West Environmental Group Ltd) engaged in international assignments with IFIs, UN Agencies, and private sector clients on the project management and technical support assignments related to waste management (hazardous, municipal, chemical), contaminated sites, circular economy, institutional technical assistance, chemicals related convention implementation (Stockholm, Basel, Montreal Protocol). Specifically relevant to TEAP related activities, this periodically includes preparation and implementation of GEF and MLF projects involving Kl Ps, end of life controlled substance management, assessment of halogenated chemicals destruction technologies, and general country level compliance with Montreal Protocol obligations. Primary personal volunteer interests include environmental and natural spaces protection in the Canadian Rockies and Northern Canada undertaken through membership in and working with local ENGOs and board memberships including the Oldman Watershed Council in Southern Alberta.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. No current property interests but consulting interests periodically involve evaluation of destruction technologies. Such involvement if linked to TEAP would be declared.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Man-West Environmental Group Ltd, - President (See Section 2 above). Director- Oldman Watershed Council
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: See Section 2 above
5. The source of funding for my participation in the work of TEAP is my company/employer and personal resources, all of which is considered a voluntary pro-bono, non-tax deductible, contribution to the work of the Montreal Protocol.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Richard J Cooke
Date: 2026-01-19

I, Şerife Erçel, residing in Türkiye, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I have over 25 years’ experience in waste management, covering development and supervision of municipal, solid and hazardous waste management investment projects, contaminated sites, POPs management and stockpile elimination, ozone depleting situations management, qualification of halogenated waste treatment/destruction technologies, chemicals related convention implementation (Stockholm, Basel, Montreal Protocol). Directly relevant to this assignment, I have undertaken lead role assignments on project management (on many private and public financed waste projects and GEF financed projects (POPs and chemicals under Stockholm Convention) and MLF financed projects (the controlled substances - ODS/HFCs under Montreal Protocol) for UNDP, UNIDO, covering the complete project cycle.). As a chemist (with a master's degree in environmental engineering) my core expertise lies in process design, engineering, and commissioning supervision of hazardous chemicals (including POPs, ODS/HFCs) and disposal methods (including thermal disposal and incineration).
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am manager in ERCEL Engineering and Environmental Technologies Industry and Trade Limited that provides environment consultancy service (See Section 2 above)
   • Government advice and other policy development: none
   • Paid research activities, fellowships or grants: none
   • Other interests: see section two
5. The source of funding for my participation in the work of TEAP is the United Nations Environment Programme Ozone Secretariat for expenses related to travel meetings
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Şerife Erçel
Date: 2026-02-17

I, JIN FANG, residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am (Principal Investigator at the Guangzhou National Laboratory). My responsibilities include (Research and development of inhalation preparation，engaged in the research and development of new drug formulations and their major varieties, committed to the development of innovative drugs and high-end formulations for chronic respiratory diseases).
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. I am one of the inventors of granted MDI related patents. In China, the patent inventor does not have patent rights and interests. I have not obtained any economic benefit from them.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am currently a member of the Chinese Pharmacopoeia Committee, participating in the formulation of Chinese Pharmacopoeia related to inhaled preparations; the chairman of the Pharmaceutical Engineering Committee and participates in the conference organization of pharmaceutical industry including inhaled preparations. Both the above special committees are non-profit organizations. And as PI in Institute of respiratory diseases, Guangzhou Medical University, engaged in inhalation related scientific research work.
   • Government advice and other policy development: I drafted China's National Strategy for CFCs Elimination in MDIs and the Action Plan for Replacing Halon in Chinese Metered Dose Inhaler.
   • Paid research activities, fellowships or grants: I have been funded by the National Pharmacopoeia Committee to study the general principles of inhalation preparations, and funded by the Ministry of science and technology of the People’s Republic of China to carry out the research on the pharmaceutical compositions and preparation methods of benzocycloquinium bromide inhalation aerosol, salbutamol sulfate aerosol and inhalation pressure quantitative aerosol.
   • Other interests: None
5. Self-funding or by MCTOC (funding for travel to meetings will be provided by UNEP's Ozone Secretariat)
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: JIN FANG
Date: 2026-01-29

I, Sue Holmes, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an independent consultant providing CMC regulatory advice to multiple pharmaceutical companies on regulatory requirements and submission strategies. Prior to consulting I was a Regulatory Affairs Director at GSK, which is an entity with an interest in the Montreal Protocol.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I own shares in my former employer, GSK.
   • Employment, consultancy, directorship or other positions: Independant consultant providing services to multiple companies, including companies with an interest in the Montreal Protocol.
   • Government advice and other policy development: N/A
   • Paid research activities, fellowships or grants: N/A
   • Other interests: N/A
5. The source of funding for my participation in the work of TEAP is self-funded.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Sue Holmes
Date: 2026-01-29

I, Jianxin Hu, residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Professor of Environmental Sciences at Peking University in China. My responsibilities include teaching and researching environmental management on Chemicals, especially related to HFCs, ozone-depleting substances, and persistent organically pollutants.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: None
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is UNEP.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Jianxin Hu
Date: 2026-01-21

I, Hu Junjie, residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a professorate senior engineer of Solid Waste and Chemicals Management Center of the Ministry of Ecology and Environment of China. My responsibilities include researching environmental management on Chemicals, especially related to refrigerant recovery, reclamation and destruction in the dismantling industry of scrapped refrigeration equipment.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: None
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is UNEP.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Hu Junjie
Date: 2026-01-19

I, Ryan Hulse, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Sr Director of Research and Development at Solstice. Solstice has interest in the topics of the Montreal Protocol in that they are developing low global warming potential and non-ozone depletion potential alternatives to current CFC and HCFCs. My responsibilities include leading the applications team in the development of new products in the areas Aerosol, Solvent, MDI, Refrigerants and Foam Blowing Agents. I also lead the process development team at Solstice which is responsible for developing new manufacturing process.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. As part of my work at Solstice I have developed aerosol, solvent, and manufacturing processes for alternatives to CFC and HCFCs. These rights for the patents are wholly owned by Solstice.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Employed by Solstice.
   • Government advice and other policy development: none
   • Paid research activities, fellowships or grants: none
   • Other interests: none
5. The source of funding for my participation in the work of TEAP is from Solstice.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Ryan Hulse
Date: 2026-01-28

I, Patsy Jeffery, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Head- Global Respiratory, Business Development & Portfolio. In addition to Respiratory, I also manage B2B (Business to Business) & Alliance Management of 15 + active Partnerships for in-market products/Lead Business Review for key partnerships/ Business growth/ Responsible for internal and external Stakeholder management. In addition, I manage CMO Business for US Market- Identify, Negotiate, enter into Agreements, and manage Alliances with CMOs for Complex generic products/Sterile Injectables etc. with the aim to de-risk/find solutions for difficult to make technologies. Leads the in-licensing opportunities, Co-development deals, Drive Divestments deals of Cipla’s US Assets; Select Out-licensing opportunities; Select Strategic Technology deals for US/Global markets to enhance Capability building of Cipla, Select Acquisitions for US Market. Under Global Respiratory, I have responsibility to introduce Respiratory products to Cipla’s development pipeline; carry out strategic deals in Respiratory. Lead initiatives of Low GWP Propellant based Portfolio and Strategic Respiratory BD.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I holds Cipla shares as per ESOP policy.
   • Employment, consultancy, directorship or other positions: I am currently working in Cipla as Head- Global Respiratory, Business Development & Portfolio and I have interest to be member of MCTOC as a subject matter expert.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of income funding for my participation in the work of TEAP is Cipla and the source of travel funding for my participation in the work of TEAP is provided by UNEP.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Patsy Jeffery
Date: 2026-01-30

I, JAVAID AHMAD KHAN, residing in Pakistan, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a pulmonologist at a private medical university involved in patients care as well as in teaching undergraduate and postgraduates. As president of Pakistan Chest SOCIETY Sind chapter, I am responsible for talking to media on lung health and other respiratory related matters.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am a pulmonologist at a private medical university involved in patients care as well as in teaching undergraduate and postgraduates. As president of Pakistan Chest SOCIETY Sind chapter, I am responsible for talking to media on lung health and other respiratory related matters.
   • Government advice and other policy development: Yes, when my opinion is asked on health related issues.
   • Paid research activities, fellowships or grants: As professor in an academic institution, I also do research which is funded by various funding agencies. My area of interest is tobacco control. I do not receive any money from a tobacco company. Funding for tobacco control received from campaign for tobacco free kids, NIHR UK University of York UK.
   • Other interests: Tobacco control efforts and raising voice on environmental pollution and climate change.
5. The source of funding for my participation in the work of TEAP is UNEP's Ozone Secretariat.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: JAVAID AHMAD KHAN
Date: 2026-01-20

I, Markus Laubscher, residing in Bulgaria, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am managing director of Orbia's medical propellant business unit, one of the world's leading manufacturers and suppliers of medical propellants for pMDI's ("ZEPHEX" brand).
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. A small number of shares in Orbia, the parent company.
   • Employment, consultancy, directorship or other positions: I am currently employed by Orbia Fluor & Energy Materials, a global company manufacturing HFCs and their replacements.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is from Orbia.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Markus Laubscher
Date: 2026-02-09

I, Andy Lindley, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an independent consultant providing services to EFCTC and Orbia. My responsibilities for the European Fluorocarbon Technical Committee (EFCTC) are mainly focused on HFCs and HFOs, their applications and EFCTC website content development and newsletter production.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am an independent consultant providing services to the European Fluorocarbon Technical Committee (EFCTC) and Orbia
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is none as no funding is required for my participation as a corresponding member
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Andy Lindley
Date: 2026-01-09

I, Rabinder N Kaul, residing in India, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a consultant and presently also Secretary of the Refrigerant Gas Manufacturers Association in India. My responsibilities include work related to Montreal Protocol and related treaties and the regulatory issues.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. Have some shares
   • Employment, consultancy, directorship or other positions: Same as above
   • Government advice and other policy development: Do not provide advice on significant issues to a Government in respect of policy.
   • Paid research activities, fellowships or grants: I do not receive paid research activities or any fellowships /grants relevant to the TEAP activity.
   • Other interests:
5. The source of funding for my participation in the work of TEAP is provided by Ozone Secretariat for travel and stay for MCTOC meetings only as Article 5 member participant .
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2025 after I have signed it.

Signed: Rabinder N Kaul 
Date: 2025-01-30 
 

I, Timothy James Noakes, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a technical expert on the manufacture and use of inhalation aerosol propellants. I am a consultant to Koura, the world's leading supplier of medical propellants.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. A small number of shares in Orbia, the parent company.
   • Employment, consultancy, directorship or other positions: I am a consultant to Koura, a global company manufacturing HFCs and their replacements. I work as a technical specialist with medical propellant HFCs.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is from Koura.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Timothy James Noakes
Date: 2026-01-26

I, John G. Owens, residing in United States of America, a Consulting Expert of the Fire Suppression Technical Options Committee and Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an independent consultant providing technical advice to clients on organofluorine compounds. One client, Standard Fluids Corporation, supplies alternatives to halon and other ODSs. I was formerly employed by the 3M Company which had been a manufacturer of alternatives to ODSs. 3M discontinued production of those products in 2025.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am an independent consultant to a variety of clients, one of which may be impacted by decisions taken under the Montreal Protocol. Standard Fluids Corporation supplies alternatives to halon and other ODSs.
   • Government advice and other policy development: I do not provide advice to a government or for other policy development.
   • Paid research activities, fellowships or grants: I am not a recipient of any paid research activities, fellowships or grants.
   • Other interests: I have no other interests related to the subject matter of the Technology and Economic Assessment Panel or the Montreal Protocol.
5. The source of funding for my participation in the work of TEAP is one of the clients for whom I consult. The Standard Fluids Corporation is an international chemical supplier based in the United States. Some of the products supplied by Standard Fluids Corporation are alternatives to halons and other ODSs.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: John G. Owens
Date: 2026-01-13

I, Sheng Peng, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a senior scientist and technical leader at Chemours with chemical research experience in organic chemistry, organofluorine chemistry, materials, catalysis, process, piloting, and manufacturing. My research includes HFCs, HFOs, organofluorine molecules, sustainability, and reclamation.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Employed by Chemours
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is from Chemours
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Sheng Peng
Date: 2026-01-28

I, Maximilian Plank, residing in Australia, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Global Medical Lead at GlaxoSmithKline. I lead the medical strategy for inhaled medicines including metered-dose inhalers with HFCs and alternative low global warming (GWP) propellants. I support MCTOC by providing knowledge about the treatment of respiratory diseases and the technical opportunities and challenges associated with developing inhalers with alternative low GWP propellants.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I have shares and share options in GlaxoSmithKline which currently develops and manufactures inhaled products for respiratory treatments (including pMDIs).
   • Employment, consultancy, directorship or other positions: I am currently working at GlaxoSmithKline as Global Medical Lead in respiratory supporting the development of metered-dose inhalers with low GWP propellants. My employer has an interest in the work of the committee and the outcomes of the Montreal Protocol and I have an interest to be a member of the MCTOC as a subject matter expert.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is GlaxoSmithKline/Personal.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Maximilian Plank
Date: 2026-02-11

I, John Pritchard, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am acting as an independent consultant to clients developing respiratory drugs, delivery systems and digital healthcare, trading under the company name of Inspiring Strategies.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. My wife and I have minority ownership of shares in various pharmaceutical companies who develop, manufacture and sell respiratory products that are impacted by decisions taken under the Montreal Protocol.
   • Employment, consultancy, directorship or other positions: I am Chairman of Cardiff Scintigraphics, a contract research organisation providing formulation development and testing of inhaled products, and who possess IP in this space. In addition, I am Chairman of Acu-flow, a company developing novel nebuliser technology and Chairit one Advisory Board for a company developing a novel dry powder inhaler. Beyond this, I consult to a variety of clients, some of whom may be commercially impacted by decisions taken under the Montreal Protocol.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. I currently receive no funding for my participation in the work of TEAP. Travel expenses might in the future be supported either by client relationships or the UK Government.
6. Pursuant to paragraph 11 of the COI Guidelines, I have declined to disclose confidential information falling within paragraph 10 of those Guidelines, namely the identity of my clients. I currently have no client contracts that would represent a conflict of interest. However, should I be engaged by such a client in the future, I will update my DoI within 30 days and recuse myself from any decisions that would materially affect them.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: John Pritchard
Date: 2026-01-28

I, Rabbur Reza, residing in Bangladesh, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. 2. I, Rabbur Reza, residing in Bangladesh, a Member of the Medical and Chemicals Technical Options Committee, declare as follows: I work as a full-time Chief Operating Officer at Beximco Pharmaceuticals PLC, Bangladesh; as Managing Director at Nuvista Pharma PLC, Bangladesh; and as Chief Executive Officer of Synovia Pharma PLC, Bangladesh. As the operational leader, I am overseeing these Company’s business operations, which include pharmaceutical formulation and raw material manufacturing & quality control, research & development, regulatory affairs, training (learning & development management), sales, marketing and brand management, distribution, international business development, informational technology, medical affairs, project management, human resources, etc.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. My employer, Beximco Pharmaceuticals, is the largest medical inhaler (pMDI & DPI) manufacturer in Bangladesh and has an interest in the topics of the Montreal Protocol, as it is engaged in the development, manufacturing, and marketing of MDIs in local and international markets. I have no proprietary interest in alternatives or substitutes to ODS.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I work as full time Chief Operating Officer at Beximco Pharmaceuticals PLC, Bangladesh, as Managing Director at Nuvista Pharma PLC., Bangladesh and as Chief Executive Officer of Synovia Pharma PLC, Bangladesh. I also serve as a Director on the board of BioCare Manufacturing Sdn Bhd., Malaysia. BioCare is involved in manufacturing MDIs. My spouse is a medical practitioner and has no interest in matters before the Protocol.
   • Government advice and other policy development: None.
   • Paid research activities, fellowships or grants: None.
   • Other interests: None.
5. The source of funding for my participation in the work of TEAP is UNEP’s Ozone Secretariat, which funds my travel expenses for participation on MCTOC.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Rabbur Reza
Date: 2026-02-01

I, Bettina Schreck, residing in Spain, a Member of the Medical and Chemicals Technical Options Committee and Member of the TEAP Replenishment Task Force (RTF) declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I work as consultant in sustainability, focused on climate change issues, spanning from policy design, technology adoption and financing. I do this work in affiliation with other firms and independently. These include organisations dealing with refrigerant life cycle management, bilateral agencies to Montreal Protocol and UNFCCC related climate issues. All consultancies are conducted on a short-term assignment basis or projects.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am affiliated as a consultant to HEAT GmbH (Germany)
   • Government advice and other policy development: I provide technical assistance related to environmental protection and climate policies
   • Paid research activities, fellowships or grants: none
   • Other interests: none
5. The source of funding for my participation in the work of TEAP is UNEP Ozone Secretariat
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Bettina Schreck
Date: 2026-01-26

I, Peter Sleigh, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I retired from working as the Regulatory manager for Koura at the end of 2022 and I am now acting as an independent consultant providing occasional services to Koura. Koura has an interest in the topics of the Montreal Protocol because they sell fluorochemicals controlled by the protocol.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Occasional Consultancy for Koura
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is currently self funding for 2026 as funding demands are expected to be limited.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Peter Sleigh
Date: 2026-01-09

I, Kristine Whorlow AM, residing in Australia, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I have extensive experience in producing and disseminating the Australian treatment guidelines for asthma based on the latest evidence, medical and environmental; conducting ongoing asthma education workshops for health professionals based on the guidelines; instigating and conducting outreach programs in Asia Pacific.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: None
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None relevant
5. The source of funding for my participation in the work of TEAP is myself.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Kristine Whorlow AM
Date: 2026-01-19

I, Alexander Wilkinson, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Consultant Respiratory Physician at the East and North Hertfordshire NHS Teaching Trust.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have participated in lectures and research activity relating to respiratory medicine and environmental sustainability which have been supported by pharmaceutical companies (including GlaxoSmithKline, AstraZeneca and Orion Pharma). No personal payments or honoraria have been received.
   • Government advice and other policy development: I work with the British Thoracic Society on their sustainable care policies.
   • Paid research activities, fellowships or grants: Nil
   • Other interests: Nil
5. The source of funding for my participation in the work of TEAP is East and North Hertfordshire NHS Teaching Trust, which allows me to take leave and provides travel support to attend meetings. I work voluntarily as Member of MCTOC.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Alexander Wilkinson
Date: 2026-02-10

I, Gerallt Williams, residing in France, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a retired medical aerosol scientist.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: none
   • Government advice and other policy development: none
   • Paid research activities, fellowships or grants: none
   • Other interests: none
5. The source of funding for my participation in the work of TEAP is personal.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Gerallt Williams
Date: 2026-01-16

I, Ashley Woodcock, residing in United Kingdom of Great Britain and Northern Ireland, a Co-chair of the Technology and Economic Assessment Panel (TEAP) and Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Professor of Respiratory Medicine at University of Manchester, and Consultant Physician at the Manchester University NHS Foundation Trust. I am Chairman of Axalbion and Board Member for Reacta Healthcare neither of which have related activities to the Montreal Protocol. I am a voluntary Trustee the British Medical Association Foundation and the North West Lung Centre Charity, and Advisor to the JP Moulton Charity, none of which have activities related to the Montreal Protocol I have received an honorarium from GlaxoSmithKline in Sept 2025 for participating in an education session on "Green inhalers".
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am Chairman of Axalbion and Board Member for Reacta Healthcare neither of which have related activities to the Montreal Protocol. I am a voluntary Trustee the British Medical Association Foundation and the North West Lung Centre Charity, and Advisor to the JP Moulton Charity, none of which have activities related to the Montreal Protocol I have received an honorarium from GlaxoSmithKline in Sept 2025 for participating in an education session on "Green inhalers".
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of travel funding for my participation in the work of TEAP is the University of Manchester and Manchester University NHS Foundation Trust.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Ashley Woodcock
Date: 2026-01-08

I, Nee Sun Choong Kwet Yive, residing in Mauritius, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an independent expert
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: No
   • Government advice and other policy development: No
   • Paid research activities, fellowships or grants: No
   • Other interests: No
5. The source of funding for my participation in the work of TEAP is UNEP
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Nee Sun Choong Kwet Yive
Date: 2026-01-29

I, Arzu Yorgancıoğlu, residing in Türkiye, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a professor in Respiratory Medicine at Celal Bayar University, Medical Faculty, Department of Pulmonology. My main area is obstructive lung diseases and inhaler therapy. I see patients both in out and inpatient clinics . I also teach and make research. I am immediate past Chair of GINA Board of Directors and Vice President of ERS
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have received honoraria from pharmaceutical companies for advisory boards and presenting (Astra Zeneca, Abdiİbrahim, Bilim , Chiesi)
   • Government advice and other policy development: I have been the Chair of WHO GARD ,now member of Steering Committee. I have served as Chair of ERS Advocacy and currently elected as vice president . I am the immediate past chair of GINA Board of directors and now a member of GINA Board
   • Paid research activities, fellowships or grants: I had institutional grants from Astra Zeneca and Sanofi for clinical trials
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is the United Nations Environment Programme Ozone Secretariat for expenses related to travel meetings
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Arzu Yorgancıoğlu
Date: 2026-01-29

I, Lifei Zhang, residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am the Professor and Director of Research Office of Convention Implementation Monitoring, National Research Center for Environmental Analysis and Measurement, Environmental Development Center of the Ministry of Ecology and Environment of China. My current research focuses on environmental monitoring and standardization, including monitoring related to ODS and HFCs, Hg, and POPs etc. international conventions; investigation monitoring for major regions and basins in China; developing national environmental monitoring standards, environmental planning and assessment, and chemical decomposition technologies on organic compounds and its mechanisms.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: None
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is UNEP.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Lifei Zhang
Date: 2026-02-02